Importance Human papillomavirus (HPV) is the most common sexually transmitted infection
in the United States, and oral HPV infection is associated with increased risk of …

Background A 9-valent human papillomavirus (HPV6/11/16/18/31/33/45/52/58; 9vHPV)
vaccine was developed to expand coverage of the previously developed quadrivalent …

Objectives. We conducted a longitudinal study to examine human papillomavirus (HPV)
vaccine uptake among male adolescents and to identify vaccination predictors. Methods. In …

Specific adult populations known to be at high risk for human papillomavirus (HPV)-related
disease, such as men who have sex with men, are inconsistently included in national …

Materials and Methods: The 2016 NIS-Teen data, an annual survey conducted by the CDC
to monitor vaccination uptake in the United States is used for this study. Multivariable logistic …

Human papillomavirus (HPV) infection, the most common sexually transmitted disease in the
US, is a preventable cause of cancer. HPV vaccination has the potential to prevent 90% of …

OBJECTIVES: The human papillomavirus (HPV) vaccine was recommended in 2006 for girls
and in 2011 for boys. The Healthy People 2020 goal for 2-dose HPV vaccination coverage is …

Background Incidence of condyloma, or genital warts (GW), is the earliest possible disease
outcome to measure when assessing the effectiveness of human papillomavirus (HPV) …

Purpose The aims of this study were to determine prevalence of and factors associated with
any human papillomavirus (HPV) and vaccine-type HPV among young men after vaccine …

OBJECTIVE: To determine the prevalence of high-risk (cancer-associated) human
papillomavirus (HPV) infection in US women, identify sociodemographic factors associated …